Table 1.
Coverage of SMC defined as proportion of children who received SMC drugs at day 1 and days 1–3 according to the source of the information (interview or SMC card) during the coverage survey
| Interviewa | SMC cardb | |||||
|---|---|---|---|---|---|---|
| n/N | % | 95% CI | n/N | % | 95% CI | |
| Received at least the first day treatment of SMC at: | ||||||
| Round 1 | 896/1170 | 83.7 | 75.6–91.9 | 664/766 | 86.7 | 82.0–91.3 |
| Round 2 | 903/1101 | 82.0 | 74.7–89.3 | 610/790 | 77.2 | 68.7–85.7 |
| Round 3 | 845/1116 | 75.7 | 67.6–83.8 | 523/797 | 65.6 | 55.4–75.8 |
| Round 4 | 752/1118 | 67.3 | 59.0–75.5 | 463/796 | 58.2 | 46.3–70.0 |
| Rounds 1, 2, 3 and 4 | 563/1046 | 53.8 | 44.5–63.1 | 309/760 | 40.7 | 29.2–52.1 |
| Received all 3 days’ treatment of SMC at: | ||||||
| Round 1 | 811/1068 | 75.9 | 67.4–84.7 | – | – | |
| Round 2 | 900/1101 | 81.7 | 74.2–89.3 | – | – | |
| Round 3 | 841/1116 | 75.4 | 67.3–83.4 | – | – | |
| Round 4 | 747/1118 | 66.8 | 58.5–75.1 | – | – | |
| Rounds 1, 2, 3 and 4 | 559/1046 | 53.4 | 44.1–62.7 | – | – | |
aBased on information from interview only
bBased on information on SMC card